IntraBio Inc., a global biopharmaceutical company focused on developing and commercializing therapies for neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) has ...
Design Therapeutics Inc. DSGN stock surged during the premarket session on Monday. The move came after the company reported ...
Rare conditions can be daunting, terrifying and isolating. For the people and families affected by them, the search for a ...
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow ...